Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1997-06-10
1998-12-29
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424 121, 424 9321, 424 951, 424417, 4284022, 264 41, 264 43, 264 432, 264 46, A61K 9127
Patent
active
058537554
ABSTRACT:
A biphasic multilamellar lipid vesicle comprising a plurality of spaced apart lipid bilayers that include a liposome-forming component and optionally a biologically active agent entrapped within the lipid bilayers. The lipid vesicle also comprises peripheral aqueous solution compartments formed between the lipid bilayers and a central lipophilic core compartment substantially at the center of the multilamellar lipid vesicle.
REFERENCES:
patent: 4311707 (1982-01-01), Birnbaum et al.
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4687661 (1987-08-01), Kikuchi et al.
patent: 4761288 (1988-08-01), Mezei
patent: 4897269 (1990-01-01), Mezei
patent: 4911928 (1990-03-01), Wallach
patent: 5030453 (1991-07-01), Lenk et al.
patent: 5169637 (1992-12-01), Lenk et al.
patent: 5234767 (1993-08-01), Wallach
patent: 5260065 (1993-11-01), Mathur et al.
Adam C. Watkinson et al., "Aspects of the Transdermal Delivery of Prostaglandins"; International Journal of Pharmaceutics, 74 (1991); pp. 229-236.
Kaneto Uekama et al., "Improved Transdermal Delivery of Prostaglandin E.sub.1 through Hairless Mouse Skin: Combined Use of Carboxymethyl-ethyl-.beta.-Cyclodextrin and Penetration Enhancers"; Communications (1991); pp. 119-121.
S. Kattan et al., "Double-Blind, Cross-Over Study Comparing Prostaglandin E1 and Papaverine in Patients with Vasculogenic Impotence", Urology vol. XXXVII, No. 6, Jun. 1991, pp. 516-518.
M. Foldvari et al., "Topical Dosage Form of Liposomal Tetracaine: Effect of Additives on the In Vitro Release and In Vivo Efficacy", Journal of Controlled Release, 27, (1993), pp. 193-205.
Kishore Gollamudi S.
Mohr Judy M.
PharmaDerm Laboratories Ltd.
LandOfFree
Biphasic multilamellar lipid vesicles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphasic multilamellar lipid vesicles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphasic multilamellar lipid vesicles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1422023